ICU Medical, Inc.
ICUI
Ранг среди акций
#3992
ICU Medical, Inc., operating globally through its subsidiaries, is a medical... ICU Medical, Inc., operating globally through its subsidiaries, is a medical technology firm that specializes in the development, manufacture, and sale of devices for both infusion therapy and critical care. Their extensive product line for infusion therapy encompasses: Needlefree Connectors: Such as the MicroClave, MicroClave Clear, and NanoClave brands. Catheter Maintenance & Disinfection: Including Neutron patency devices and SwabCap/SwabTip disinfecting caps. Hemodialysis Solutions: Like Tego connectors and ClearGuard HD antimicrobial caps. Hazardous Drug Handling: With closed system transfer devices (ChemoClave, ChemoLock) and the Diana compounding system for safe preparation. They also provide a comprehensive range of intravenous (IV) solutions, diluents, and irrigation fluids, available in diverse packaging options like flexible containers and pour bottles. These include common formulations such as sodium chloride, dextrose, balanced electrolytes, lactated ringer's, mannitol, and sterile water, alongside specialized irrigation solutions like acetic acid and glycine. In medication management, ICU Medical offers sophisticated infusion pumps, including the Plum 360 and LifeCare PCA brands. Its advanced ICU Medical MedNet software enhances medication safety by integrating smart pumps with hospital electronic health records (EHRs), asset tracking, and alarm notification platforms. Accompanying professional services are also provided. For critical care environments, their portfolio features: Hemodynamic Monitoring: Systems like Cogent 2-in-1 and CardioFlo. Cardiac Output & Oximetry: TDQ, OptiQ, and TriOx catheters. Blood Pressure Transducers: Such as Transpac. Blood Sampling Systems: Including the SafeSet closed blood sampling and conservation systems. The company distributes its products to a wide spectrum of healthcare providers, including acute care hospitals, wholesalers, ambulatory clinics, and various alternate site facilities such as outpatient clinics, home healthcare services, and long-term care centers. Established in 1984, ICU Medical maintains its headquarters in San Clemente, California.
Цена акции
$162.74
Последняя синхронизация: 2026-10-16
Рыночная капитализация
$4.07B
Изменение (1 день)
-2.68%
Изменение (1 год)
37.38%
Страна
US
Торговля ICU Medical, Inc. (ICUI)
Категория
Healthcare
Операционная маржа для ICU Medical, Inc. (ICUI)
Операционная маржа на October 2026 TTM: 5.04%
Согласно последним финансовым отчетам и цене акций ICU Medical, Inc., текущая операционная маржа (TTM) составляет 5.04%. В конце 2023 она составила 1.01%.
История операционной маржи ICU Medical, Inc. с 2000 по 2026
Операционная маржа на конец каждого года
| Год | Операционная маржа | Изменить |
|---|---|---|
| 2026 (TTM) | 5.04% | 180.00% |
| 2024 | 1.80% | 78.22% |
| 2023 | 1.01% | -153.72% |
| 2022 | -1.88% | -120.09% |
| 2021 | 9.36% | 21.24% |
| 2020 | 7.72% | 54.71% |
| 2019 | 4.99% | 224.03% |
| 2018 | 1.54% | -231.62% |
| 2017 | -1.17% | -105.35% |
| 2016 | 21.86% | 8.92% |
| 2015 | 20.07% | 59.03% |
| 2014 | 12.62% | -23.79% |
| 2013 | 16.56% | -14.37% |
| 2012 | 19.34% | -10.38% |
| 2011 | 21.58% | 24.60% |
| 2010 | 17.32% | 5.61% |
| 2009 | 16.40% | 6.98% |
| 2008 | 15.33% | 17.02% |
| 2007 | 13.10% | -14.44% |
| 2006 | 15.31% | -12.61% |
| 2005 | 17.52% | 123.75% |
| 2004 | 7.83% | -75.37% |
| 2003 | 31.79% | -6.97% |
| 2002 | 34.17% | 6.68% |
| 2001 | 32.03% | 8.28% |
| 2000 | 29.58% | 0.00% |
Операционная маржа для аналогичных компаний или конкурентов
| Компания | Операционная маржа | Разница в операционной марже | Страна |
|---|---|---|---|
| 31.28% | -93.79% |
US
|
|
| 12.36% | -97.55% |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | -98.05% |
US
|
|
| 0.00% | - |
CH
|
Что такое операционная маржа компании?
Операционная маржа — это ключевой показатель прибыльности компании. Более высокая операционная маржа обычно означает, что компания может продавать свои товары или услуги значительно дороже их себестоимости. Она рассчитывается путем деления прибыли компании на её выручку.